Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1970 | 2403 | 33.3 | 78% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
176 | 3 | DIABETES CARE//ENDOCRINOLOGY & METABOLISM//TYPE 2 DIABETES | 58057 |
79 | 2 | DIABETES CARE//DIABETES EDUCATOR//DIABETIC MEDICINE | 27337 |
1970 | 1 | INSULIN GLARGINE//BIPHASIC INSULIN ASPART 30//INSULIN INITIATION | 2403 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | INSULIN GLARGINE | authKW | 637815 | 5% | 38% | 132 |
2 | BIPHASIC INSULIN ASPART 30 | authKW | 458660 | 2% | 95% | 38 |
3 | INSULIN INITIATION | authKW | 354763 | 1% | 85% | 33 |
4 | PREMIXED INSULIN | authKW | 339154 | 1% | 86% | 31 |
5 | BIPHASIC INSULIN ASPART | authKW | 313061 | 1% | 79% | 31 |
6 | TYPE 2 DIABETES | authKW | 248296 | 21% | 4% | 511 |
7 | INSULIN THERAPY | authKW | 222144 | 4% | 17% | 101 |
8 | PSYCHOLOGICAL INSULIN RESISTANCE | authKW | 215991 | 1% | 100% | 17 |
9 | INSULIN DETEMIR | authKW | 212562 | 2% | 36% | 47 |
10 | BASAL INSULIN | authKW | 203544 | 2% | 32% | 50 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Endocrinology & Metabolism | 49598 | 55% | 0% | 1320 |
2 | Medicine, General & Internal | 7482 | 26% | 0% | 636 |
3 | Primary Health Care | 4972 | 5% | 0% | 111 |
4 | Health Care Sciences & Services | 496 | 3% | 0% | 84 |
5 | Medicine, Research & Experimental | 370 | 6% | 0% | 139 |
6 | Health Policy & Services | 165 | 2% | 0% | 39 |
7 | Cardiac & Cardiovascular System | 147 | 4% | 0% | 106 |
8 | Pharmacology & Pharmacy | 125 | 7% | 0% | 167 |
9 | Geriatrics & Gerontology | 100 | 1% | 0% | 33 |
10 | Public, Environmental & Occupational Health | 78 | 4% | 0% | 91 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | STUDY PROF HANEFELD | 101635 | 0% | 67% | 12 |
2 | DIABETOL METAB ENDOCRINOL | 62252 | 0% | 70% | 7 |
3 | CIPTO MANGUNKUSOMO HOSP | 52937 | 0% | 83% | 5 |
4 | HERZ DIABET ZENTRUM NORDRHEIN WESTFALEN BAD OEY | 39701 | 0% | 63% | 5 |
5 | CELLULAR MED DIABET | 38711 | 0% | 38% | 8 |
6 | GLOBAL METAB | 38116 | 0% | 100% | 3 |
7 | MED ABT RHEUMATOL STOFFWECHSELERKRANKUNGEN REHA | 33878 | 0% | 67% | 4 |
8 | DIABET TRIALS UNIT | 29799 | 1% | 13% | 18 |
9 | DIABET | 28970 | 6% | 2% | 146 |
10 | MUNICH DIABET | 28870 | 0% | 45% | 5 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | DIABETES OBESITY & METABOLISM | 105095 | 6% | 6% | 135 |
2 | DIABETES THERAPY | 63126 | 1% | 17% | 30 |
3 | PRIMARY CARE DIABETES | 60431 | 2% | 12% | 40 |
4 | DIABETES CARE | 56380 | 9% | 2% | 225 |
5 | DIABETES RESEARCH AND CLINICAL PRACTICE | 48994 | 6% | 3% | 143 |
6 | DIABETES TECHNOLOGY & THERAPEUTICS | 21753 | 2% | 4% | 48 |
7 | DIABETIC MEDICINE | 20485 | 4% | 2% | 96 |
8 | DIABETES EDUCATOR | 18009 | 2% | 4% | 40 |
9 | CURRENT MEDICAL RESEARCH AND OPINION | 16383 | 3% | 2% | 76 |
10 | DIABETOLOGE | 15372 | 1% | 5% | 23 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | INSULIN GLARGINE | 637815 | 5% | 38% | 132 | Search INSULIN+GLARGINE | Search INSULIN+GLARGINE |
2 | BIPHASIC INSULIN ASPART 30 | 458660 | 2% | 95% | 38 | Search BIPHASIC+INSULIN+ASPART+30 | Search BIPHASIC+INSULIN+ASPART+30 |
3 | INSULIN INITIATION | 354763 | 1% | 85% | 33 | Search INSULIN+INITIATION | Search INSULIN+INITIATION |
4 | PREMIXED INSULIN | 339154 | 1% | 86% | 31 | Search PREMIXED+INSULIN | Search PREMIXED+INSULIN |
5 | BIPHASIC INSULIN ASPART | 313061 | 1% | 79% | 31 | Search BIPHASIC+INSULIN+ASPART | Search BIPHASIC+INSULIN+ASPART |
6 | TYPE 2 DIABETES | 248296 | 21% | 4% | 511 | Search TYPE+2+DIABETES | Search TYPE+2+DIABETES |
7 | INSULIN THERAPY | 222144 | 4% | 17% | 101 | Search INSULIN+THERAPY | Search INSULIN+THERAPY |
8 | PSYCHOLOGICAL INSULIN RESISTANCE | 215991 | 1% | 100% | 17 | Search PSYCHOLOGICAL+INSULIN+RESISTANCE | Search PSYCHOLOGICAL+INSULIN+RESISTANCE |
9 | INSULIN DETEMIR | 212562 | 2% | 36% | 47 | Search INSULIN+DETEMIR | Search INSULIN+DETEMIR |
10 | BASAL INSULIN | 203544 | 2% | 32% | 50 | Search BASAL+INSULIN | Search BASAL+INSULIN |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | VAAG, A , LUND, S , (2012) INSULIN INITIATION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: TREATMENT GUIDELINES, CLINICAL EVIDENCE AND PATTERNS OF USE OF BASAL VS PREMIXED INSULIN ANALOGUES.EUROPEAN JOURNAL OF ENDOCRINOLOGY. VOL. 166. ISSUE 2. P. 159-170 | 61 | 82% | 19 |
2 | LIEBL, A , PRUSTY, V , VALENSI, P , KAWAMORI, R , CHRISTIANSEN, JS , PALMER, AJ , BALSCHMIDT, P , LIGTHELM, R , MOHAN, V , (2012) TEN YEARS OF EXPERIENCE WITH BIPHASIC INSULIN ASPART 30 FROM DRUG DEVELOPMENT TO THE LATEST CLINICAL FINDINGS.DRUGS. VOL. 72. ISSUE 11. P. 1495-1520 | 69 | 75% | 11 |
3 | CAI, XL , LUO, YY , HAN, XY , JI, LN , (2013) EFFICACY AND SAFETY OF INSULIN TREATMENT IN TYPE 2 DIABETES USING A NEW INDEX CALLED GLUCOSE SAFETY CONTROL INDEX.CHINESE MEDICAL JOURNAL. VOL. 126. ISSUE 21. P. 4166-4174 | 54 | 96% | 2 |
4 | PONTIROLI, AE , MIELE, L , MORABITO, A , (2012) METABOLIC CONTROL AND RISK OF HYPOGLYCAEMIA DURING THE FIRST YEAR OF INTENSIVE INSULIN TREATMENT IN TYPE 2 DIABETES: SYSTEMATIC REVIEW AND META-ANALYSIS.DIABETES OBESITY & METABOLISM. VOL. 14. ISSUE 5. P. 433 -446 | 64 | 77% | 16 |
5 | GIUGLIANO, D , MAIORINO, M , BELLASTELLA, G , CHIODINI, P , ESPOSITO, K , (2011) RELATIONSHIP OF BASELINE HBA1C, HBA1C CHANGE AND HBA1C TARGET OF < 7% WITH INSULIN ANALOGUES IN TYPE 2 DIABETES: A META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS.INTERNATIONAL JOURNAL OF CLINICAL PRACTICE. VOL. 65. ISSUE 5. P. 602 -612 | 67 | 74% | 11 |
6 | ESPOSITO, K , MAIORINO, MI , BELLASTELLA, G , CHIODINI, P , GIUGLIANO, D , (2011) INSULIN ANALOGS AND GLYCOSYLATED HEMOGLOBIN TARGET OF LESS THAN 7% IN TYPE 2 DIABETES: A SYSTEMATIC REVIEW OF RANDOMIZED TRIALS.METABOLIC SYNDROME AND RELATED DISORDERS. VOL. 9. ISSUE 3. P. 167 -176 | 69 | 73% | 1 |
7 | RYS, P , WOJCIECHOWSKI, P , ROGOZ-SITEK, A , NIESYCZYNSKI, G , LIS, J , SYTA, A , MALECKI, MT , (2015) SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CLINICAL TRIALS COMPARING EFFICACY AND SAFETY OUTCOMES OF INSULIN GLARGINE WITH NPH INSULIN, PREMIXED INSULIN PREPARATIONS OR WITH INSULIN DETEMIR IN TYPE 2 DIABETES MELLITUS.ACTA DIABETOLOGICA. VOL. 52. ISSUE 4. P. 649 -662 | 51 | 77% | 8 |
8 | CZECH, M , RDZANEK, E , PAWESKA, J , ADAMOWICZ-SIDOR, O , NIEWADA, M , JAKUBCZYK, M , (2015) DRUG-RELATED RISK OF SEVERE HYPOGLYCAEMIA IN OBSERVATIONAL STUDIES: A SYSTEMATIC REVIEW AND META-ANALYSIS.BMC ENDOCRINE DISORDERS. VOL. 15. ISSUE . P. - | 82 | 51% | 1 |
9 | LEAHY, JL , (2012) INSULIN THERAPY IN TYPE 2 DIABETES MELLITUS.ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA. VOL. 41. ISSUE 1. P. 119-+ | 70 | 63% | 8 |
10 | PONTIROLI, AE , MIELE, L , MORABITO, A , (2011) INCREASE OF BODY WEIGHT DURING THE FIRST YEAR OF INTENSIVE INSULIN TREATMENT IN TYPE 2 DIABETES: SYSTEMATIC REVIEW AND META-ANALYSIS.DIABETES OBESITY & METABOLISM. VOL. 13. ISSUE 11. P. 1008 -1019 | 48 | 80% | 43 |
Classes with closest relation at Level 1 |